SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-086959
Filing Date
2023-11-14
Accepted
2023-11-14 16:15:21
Documents
13
Period of Report
2023-11-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188215-8k_silo.htm   iXBRL 8-K 20816
2 THIRD AMENDMENT TO MASTER LICENSE AGREEMENT ea188215ex10-1_silo.htm EX-10.1 16199
  Complete submission text file 0001213900-23-086959.txt   207480

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE silo-20231110.xsd EX-101.SCH 3021
4 XBRL LABEL FILE silo-20231110_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE silo-20231110_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea188215-8k_silo_htm.xml XML 3028
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 231406427
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl